2026-W46 · Nov 9–Nov 15 · Company · Profile · published
IDEXX company profile · veterinary diagnostics, water testing & livestock · history · financial snapshot · S&P 500 rank #256 · 愛德士公司業務歷史財務與標普500地位
SNAPSHOT
| Ticker | IDXX (NASDAQ) |
| Company | IDEXX Laboratories, Inc. |
| GICS sector / industry | Health Care (XLV) / Health Care Equipment |
| S&P 500 rank (by weight) | #256 · 0.06% (Nov 2, 2026) |
| Sector rank (by S&P 500 weight) | #34 in Health Care (Nov 2, 2026) |
| Headquarters | Westbrook, Maine |
| Founded | 1983, in Westbrook, Maine |
| CEO | Jonathan J. Mazelsky (president and CEO) |
| Market cap | $43.42B (Nov 2, 2026) |
| SEC filings | EDGAR — CIK 0000874716 |
WHAT IT DOES
IDEXX makes diagnostic tests and instruments for animals: in-clinic analysers, reference laboratories, practice-management software and rapid assays for companion animals, plus water-quality tests and livestock and poultry diagnostics.
The Companion Animal Group dominates revenue — veterinary clinics run IDEXX analysers and send samples to IDEXX reference labs, generating recurring consumables and test volume. Water quality products and Livestock, Poultry and Dairy add smaller, specialised lines, and an Other segment covers human medical diagnostics and out-licensing.
FY2025 total revenue rose 10.4% to $4,303.7M, net income was $1,059.5M and diluted EPS was $13.08. Companion Animal Group revenue grew 10.6% to $3,953.3M.
BUSINESS SEGMENTS — FY2025 REVENUE
| Segment | Revenue | Share | YoY |
|---|---|---|---|
| Companion Animal Group (CAG) | $3,953.3M | 91.9% | +10.6% |
| Water quality products | $201.1M | 4.7% | +8.7% |
| Livestock, Poultry and Dairy (LPD) | $131.8M | 3.1% | +8.0% |
| Other | $17.5M | 0.4% | — |
HISTORY
| Year | Milestone |
|---|---|
| 1983 | IDEXX founded in Westbrook, Maine. |
| 1991 | Initial public offering on NASDAQ. |
| 2016 | SediVue Dx urine sediment analyser launched for in-clinic use. |
| 2025 | FY2025 revenue $4,303.7M, up 10.4%, led by Companion Animal Group. |
COMPETITIVE POSITION
FINANCIAL SNAPSHOT — FY2025
| Total revenue | $4,303.7M (+10.4% YoY, vs $3,897.5M) |
| Net income | $1,059.5M |
| Diluted EPS | $13.08 |
| Companion Animal Group revenue | $3,953.3M (+10.6% YoY) |
KEY RISKS
WHY IT MATTERS FOR THE S&P 500
IDEXX is the pet-care diagnostics leader in the index: its test volumes track pet ownership and veterinary spending, a resilient consumer-health theme.
At S&P 500 rank #256 with a 0.06% weight, it represents health care equipment inside Health Care.
SOURCES & METHODOLOGY
| Market data | Slickcharts S&P 500 by weight (rank, weight, price — Nov 2, 2026 crawl) · StockAnalysis (market cap — Nov 2, 2026 crawl, single source) |
| Financials | IDEXX Form 10-K FY2025 (filed Feb 20, 2026), consolidated statements and segment note |
| Sector classification | GICS via the List of S&P 500 companies (Wikipedia) |
| Library data | SPXSet logo library, compiled from company official websites, filings, or Wikipedia; as company logos are dynamic corporate information, no 100% guarantee is made for the graphics. SPXSet chart library, monthly bars, compiled from Yahoo public information. |
Source: Yahoo Finance monthly bars, split-adjusted · Data as of Sep 30, 2026 (last closed month) · SPXSet.com
FINANCIALS
公司快照
| 股票代號 | IDXX(NASDAQ) |
| 公司 | IDEXX Laboratories, Inc. |
| GICS 板塊/行業 | 健康護理(XLV)/Health Care Equipment |
| 標普500排名(按權重) | 第256名 · 0.06%(2026 年 11 月 2 日) |
| 板塊內排名(按標普500權重) | 健康護理第34名(2026 年 11 月 2 日) |
| 總部 | 緬因州韋斯特布魯克 |
| 成立 | 1983年,緬因州韋斯特布魯克 |
| 行政總裁 | Jonathan J. Mazelsky(總裁兼行政總裁) |
| 市值 | $43.42B(2026 年 11 月 2 日) |
| SEC 文件 | EDGAR — CIK 0000874716 |
業務概覽
愛德士生產動物診斷檢測與儀器:診所內分析儀、參考實驗室、診所管理軟件與快速檢測,服務伴侶動物;另有水質檢測與畜禽診斷。
伴侶動物集團佔收入主導——獸醫診所使用愛德士分析儀並將樣本送往愛德士參考實驗室,帶來經常性耗材與檢測量。水質產品與畜禽乳品為較小的專業業務;其他板塊涵蓋人類醫學診斷與對外授權。
FY2025 總收入增長 10.4% 至 43.037 億美元,淨利潤 10.595 億美元,攤薄每股收益 13.08 美元。伴侶動物集團收入增長 10.6% 至 39.533 億美元。
業務板塊 — FY2025 收入
| 板塊 | 收入 | 佔比 | 同比 |
|---|---|---|---|
| 伴侶動物集團(CAG) | $3,953.3M | 91.9% | +10.6% |
| 水質產品 | $201.1M | 4.7% | +8.7% |
| 畜禽乳品(LPD) | $131.8M | 3.1% | +8.0% |
| 其他 | $17.5M | 0.4% | — |
歷史沿革
| 年份 | 里程碑 |
|---|---|
| 1983 | 愛德士於緬因州韋斯特布魯克成立。 |
| 1991 | 納斯達克首次公開招股。 |
| 2016 | 推出診所用 SediVue Dx 尿沉渣分析儀。 |
| 2025 | FY2025 收入 43.037 億美元,同比增長 10.4%,由伴侶動物集團帶動。 |
競爭地位
財務快照 — FY2025
| 總收入 | $4,303.7M(同比 +10.4%,上年 $3,897.5M) |
| 淨利潤 | $1,059.5M |
| 攤薄每股收益 | $13.08 |
| 伴侶動物集團收入 | $3,953.3M(同比 +10.6%) |
主要風險
對標普500的重要性
愛德士是指數中的寵物護理診斷龍頭:其檢測量跟蹤寵物飼養與獸醫開支,屬具韌性的消費健康主題。
標普500排名第256位、權重 0.06%,代表健康護理板塊內的醫療設備行業。
來源與方法
| 市場數據 | Slickcharts 標普500權重榜(排名、權重、價格——2026 年 11 月 2 日抓取)· StockAnalysis(市值——2026 年 11 月 2 日抓取,單一來源) |
| 財務 | 愛德士 FY2025 10-K(2026 年 2 月 20 日提交),合併報表與板塊附註 |
| 板塊分類 | GICS,據 S&P 500 公司清單(Wikipedia) |
| 圖庫數據 | SPXSet logo 庫,整理自企業官方網站、文件或維基百科;由於是企業自身動態資訊,不對圖形做百分百保證。SPXSet 圖表庫月線,整理自 Yahoo 公開資訊。 |
來源:Yahoo Finance 月 K(經拆股調整)· 數據截至 2026 年 9 月 30 日(最後已收月份)· SPXSet.com
財報
SPXSet in-house research — market structure, options and volatility. Not investment advice.
SPXSet 站內獨立研究,聚焦 SPX 市場結構、期權與波動率;內容不構成投資建議。
Entered 2026-11-01 20:14 · updated 2026-11-14 23:33 · rev 5